What is SK Bioscience Co Price-to-Operating-Cash-Flow?
As of today (2024-06-05), SK Bioscience Co's share price is ₩51700.00.
SK Bioscience Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩927.79. Hence, SK Bioscience Co's Price-to-Operating-Cash-Flow Ratio for today is 55.72.
The historical rank and industry rank for SK Bioscience Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
XKRX:302440'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 18.55 Med: 42.77 Max: 485.46
Current: 55.72
During the past 6 years, SK Bioscience Co's highest Price-to-Operating-Cash-Flow Ratio was 485.46. The lowest was 18.55. And the median was 42.77.
SK Bioscience Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ₩-411.90.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩927.79.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -41.90% per year.
During the past 6 years, SK Bioscience Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was -0.70% per year. The lowest was -41.90% per year. And the median was -21.30% per year.
SK Bioscience Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for SK Bioscience Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SK Bioscience Co Price-to-Operating-Cash-Flow Chart
|
SK Bioscience Co Annual Data
|
|
Trend |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
- |
- |
30.96 |
- |
188.81 |
|
SK Bioscience Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
456.47 |
188.81 |
66.07 |
Competitive Comparison of SK Bioscience Co's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, SK Bioscience Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SK Bioscience Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SK Bioscience Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where SK Bioscience Co's Price-to-Operating-Cash-Flow falls into.
SK Bioscience Co Price-to-Operating-Cash-Flow Calculation
SK Bioscience Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 51700.00 | / | 927.789 |
| = | 55.72 |
SK Bioscience Co's Share Price of today is ₩51700.00.
SK Bioscience Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩927.79.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
SK Bioscience Co (XKRX:302440) Business Description
Traded in Other Exchanges
N/A
Address
310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494
SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.
SK Bioscience Co (XKRX:302440) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:302440 has been successfully added to your